Search results for " Signature"

showing 10 items of 152 documents

From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prog…

2013

Several multigene tests have been developed for breast cancer patients to predict the individual risk of recurrence. Most of the first generation tests rely on proliferation-associated genes and are commonly carried out in central reference laboratories. Here, we describe the development of a second generation multigene assay, the EndoPredict test, a prognostic multigene expression test for estrogen receptor (ER) positive, human epidermal growth factor receptor (HER2) negative (ER+/HER2−) breast cancer patients. The EndoPredict gene signature was initially established in a large high-throughput microarray-based screening study. The key steps for biomarker identification are discussed in det…

Microarrayendocrine therapyBiomedical EngineeringBioengineeringReviewComputational biologyBiologyGene signaturemedicine.diseaseBioinformaticsIndividual riskBiochemistryFirst generationlcsh:BiochemistryMultigene expressionbreast cancerBreast cancerReal-time polymerase chain reactionmedicineProficiency testinglcsh:QD415-436multigene testEndoPredictBiotechnologyMicroarrays
researchProduct

Drug connectivity mapping and functional analysis reveal therapeutic small molecules that differentially modulate myelination

2022

Disruption or loss of oligodendrocytes (OLs) and myelin has devastating effects on CNS function and integrity, which occur in diverse neurological disorders, including Multiple Sclerosis (MS), Alzheimer’s disease and neuropsychiatric disorders. Hence, there is a need to develop new therapies that promote oligodendrocyte regeneration and myelin repair. A promising approach is drug repurposing, but most agents have potentially contrasting biological actions depending on the cellular context and their dose-dependent effects on intracellular pathways. Here, we have used a combined systems biology and neurobiological approach to identify compounds that exert positive and negative effects on olig…

MyelinMiceMyelin SheathNSC Neural stem cellSystems BiologyOPC Oligodendrocyte progenitor cellHigh-Throughput Nucleotide SequencingLINCS The Library of Integrated Network-based Cellular SignaturesCell DifferentiationGeneral MedicineCNS Central Nervous SystemOligodendrogliamedicine.anatomical_structureOligodendrogenesisNFOL Newly formed oligodendrocyteOL OligodendrocyteSignal TransductionSubventricular zoneOptic nerveIn silicoSystems biologyMorpholinesSVZ subventricular zoneContext (language use)RM1-950BiologyArticlemedicinePharmacogenomics The Library of Integrated Network-Based Cellular Signatures/LINCSAnimalsH-LY29 High concentration of LY294002Computer SimulationPI3K/AKT/mTOR pathwayL-LY29 Low concentration of LY294002PharmacologyPI3K/AktTCN TriciribineDose-Response Relationship DrugRegeneration (biology)Multiple sclerosismedicine.diseaseOligodendrocyteOligodendrocyteiNSCs iPSC-derived NSCsTAPs Transiently amplifying progenitorsMice Inbred C57BLMS Multiple SclerosisiPCS induced Pluripotent Stem CellChromonesPharmacogeneticsTherapeutics. PharmacologyMOL Myelinating oligodendrocyteNeuroscienceBiomedicine & Pharmacotherapy
researchProduct

Extending the DAMA annual-modulation region by inclusion of the uncertainties in astrophysical velocities

1999

The original annual-modulation region, singled out by the DAMA/NaI experiment for direct detection of WIMPs, is extended by taking into account the uncertainties in the galactic astrophysical velocities. Also the effect due to a possible bulk rotation for the dark matter halo is considered. We find that the range for the WIMP mass becomes 30 GeV < m_chi < 130 GeV at 1-sigma C.L. with a further extension in the upper bound, when a possible bulk rotation of the dark matter halo is taken into account. We show that the DAMA results, when interpreted in the framework of the Minimal Supersymmetric extension of the Standard Model, are consistent with a relic neutralino as a dominant componen…

Nuclear and High Energy PhysicsParticle physicsDAMA/LIBRACold dark matterDark matterFOS: Physical sciencesAstrophysics::Cosmology and Extragalactic AstrophysicsAstrophysicsAstrophysicsSettore FIS/04 - Fisica Nucleare e SubnucleareGalactic haloHigh Energy Physics - Phenomenology (hep-ph)DARK-MATTERSUPERSYMMETRYLight dark matterPhysicsDARK-MATTER; Dark matter annual modulation signature; SUPERSYMMETRY; SIGNAL;Settore FIS/01 - Fisica SperimentaleAstrophysics (astro-ph)Astrophysics::Instrumentation and Methods for AstrophysicsSIGNALDark matter haloHigh Energy Physics - PhenomenologyDark matter annual modulation signatureWeakly interacting massive particlesDAMA/NaI
researchProduct

Limits on the production of scalar leptoquarks from $Z^0$ decays at LEP

1993

A search has been made for pairs and for single production of scalar leptoquarks of the first and second generations using a data sample of 392000 Z0 decays from the DELPHI detector at LEP 1. No signal was found and limits on the leptoquark mass, production cross section and branching ratio were set. A mass limit at 95% confidence level of 45.5 GeV/c2 was obtained for leptoquark pair production. The search for the production of a single leptoquark probed the mass region above this limit and its results exclude first and second generation leptoquarks D0 with masses below 65 GeV/c2 and 73 GeV/c2 respectively, at 95% confidence level, assuming that the D0lq Yukawa coupling alpha(lambda) is equ…

Nuclear and High Energy PhysicsParticle physicsLUND MONTE-CARLOElectron–positron annihilationScalar (mathematics)Elementary particle01 natural sciencesJET FRAGMENTATIONNuclear physicsPHYSICSSEARCH0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]PARTICLESLeptoquarkE+E COLLIDERSLimit (mathematics)LUND MONTE-CARLO; JET FRAGMENTATION; E+E COLLIDERS; SEARCH; SIGNATURES; PARTICLES; PHYSICS010306 general physicsSIGNATURESPhysics010308 nuclear & particles physicsBranching fractionHigh Energy Physics::PhenomenologyYukawa potentialPair productionHigh Energy Physics::ExperimentFísica nuclearParticle Physics - Experiment
researchProduct

Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial.

2021

Abstract Background The single‐arm DAWN trial (NCT01779791) of ibrutinib monotherapy in patients with relapsed/refractory follicular lymphoma (FL) showed an overall response rate (ORR) of 20.9% and a median response duration of 19.4 months. This biomarker analysis of the DAWN dataset sought to determine genetic classifiers for prediction of response to ibrutinib treatment. Methods Whole exome sequencing was performed on baseline tumor samples. Potential germline variants were excluded; a custom set of 1216 cancer‐related genes was examined. Responder‐ versus nonresponder‐associated variants were identified using Fisher's exact test. Classifiers with increasing numbers of genes were created …

OncologyCancer ResearchFollicular lymphomaBiochemistrychemistry.chemical_compoundGenetic signaturePiperidinesRecurrenceMedicineExomeLymphoma FollicularExome sequencingRC254-282Research ArticlesNeoplasms. Tumors. Oncology. Including cancer and carcinogensHematologyDNA-Binding ProteinsExact testOncologyIbrutinibRefractory Follicular LymphomaClin oncolResearch ArticleGenetic Markersmedicine.medical_specialtyImmunologyAntineoplastic AgentslymphomaBiologyGermline mutationInternal medicinePartial responseExome SequencingHumansRadiology Nuclear Medicine and imagingIn patientbusiness.industryAdeninegenetic variantsClinical Cancer ResearchbiomarkersCell Biologymedicine.diseasemutationsFANCAMutational analysisCARD Signaling Adaptor ProteinschemistryGuanylate CyclaseFamily medicineRelapsed refractoryMutationbusinessCancer medicine
researchProduct

Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use

2015

Several gene expression-based prognostic signatures have been described in neuroblastoma, but none have successfully been applied in the clinic. Here we have developed a clinically applicable prognostic gene signature, both with regards to number of genes and analysis platform. Importantly, it does not require comparison between patients and is applicable amongst high-risk patients. The signature is based on a two-gene score (R-score) with prognostic power in high-stage tumours (stage 4 and/or MYCN-amplified diagnosed after 18 months of age). QPCR-based and array-based analyses of matched cDNAs confirmed cross platform (array-qPCR) transferability. We also defined a fixed cut-off value iden…

OncologyCancer Researchmedicine.medical_specialtyTreatment regimenbusiness.industryPatient riskTransferabilityCancerGene signaturemedicine.diseaseBioinformaticsOncologyNeuroblastomaInternal medicinemedicineStage (cooking)businessGeneInternational Journal of Cancer
researchProduct

Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes

2020

Interferons are crucial for adaptive immunity and play an important role in the immune landscape of breast cancer. Using microarray-based gene expression analysis, we examined the subtype-specific prognostic significance of interferon-&gamma

OncologyMicroarrayReceptor ErbB-2animal diseasesKaplan-Meier Estimatelcsh:ChemistryMedicinelcsh:QH301-705.5Spectroscopymolecular subtypesHazard ratioGeneral MedicineinterferonMiddle AgedAcquired immune systemProgression-Free SurvivalComputer Science ApplicationsGene Expression Regulation NeoplasticReceptors EstrogenCohortFemaleReceptors ProgesteroneSignal Transductionmedicine.medical_specialtyBreast Neoplasmschemical and pharmacologic phenomenaDisease-Free SurvivalArticleCatalysisInorganic ChemistryInterferon-gammaBreast cancerImmune systembreast cancerInternal medicineBiomarkers TumorHumansPhysical and Theoretical ChemistryMolecular BiologyAgedNeoplasm Stagingbusiness.industryProportional hazards modelOrganic Chemistrybreast cancer ; prognosis ; interferon ; molecular subtypesbiochemical phenomena metabolism and nutritionGene signaturemedicine.diseaselcsh:Biology (General)lcsh:QD1-999bacteriaprognosisbusinessInternational Journal of Molecular Sciences
researchProduct

Gene signatures in CRC and liver metastasis

2011

Colorectal cancer (CRC) is one of the most common causes of cancer-related death with a worldwide incidence of almost a million cases annually in both males and females. The accelerated decrease in CRC incidence rates from 1998 to 2006 largely reflects the advances in diagnosis and treatment that have enabled to detect and remove precancerous polyps. However, the screening technology has not resulted in major improvements in the prognosis of patients with advanced cancer and the liver metastasis remains the major cause of death in CRC. About 25% of patients have detectable liver metastasis at diagnosis, that are classified as “synchronous” lesions and approximately 70% of patients develop a…

Oncologymedicine.medical_specialtyColorectal cancerbusiness.industrySettore MED/06 - Oncologia MedicaIncidence (epidemiology)Medicine (all)DiseaseGene signaturemedicine.diseasePrecancerous Polypdigestive system diseasesMetastasisInternal medicinemedicineCancer researchbusinessGeneCause of death
researchProduct

Infrared monitoring of underground CO2 storage using chalcogenide glass fibers

2009

International audience; An optical-fiber-based system suitable for monitoring the presence of carbon dioxide, so-called "greenhouse gas", is investigated. Since each pollutant gas shows a characteristic optical absorption spectrum in the mid-infrared (mid-IR), it is possible to detect selectively and quantitatively the presence of gases in a given environment by analysing mid-IR spectra. The main infrared signature of carbon dioxide gas is a double absorption peak located at 4.2 μm. Chalcogenide optical fibers, which can transmit light in the 1-6 μm range, are well-adapted for CO2 analysis. In this wavelength range, they show attenuation losses that compare favourably with other types of fi…

Optical fiberOptical fiberAbsorption spectroscopyInfraredChalcogenideChalcogenide glass02 engineering and technology01 natural scienceslaw.invention010309 opticsInorganic Chemistrychemistry.chemical_compoundOpticsInfrared signaturelaw0103 physical sciencesCO2 storageElectrical and Electronic EngineeringPhysical and Theoretical ChemistrySpectroscopyOptical path lengthbusiness.industryAttenuationGlobal warmingOrganic Chemistry[CHIM.MATE]Chemical Sciences/Material chemistry021001 nanoscience & nanotechnologyAtomic and Molecular Physics and OpticsElectronic Optical and Magnetic Materialschemistry13. Climate action[ CHIM.MATE ] Chemical Sciences/Material chemistryChalcogenide glassOptical sensor0210 nano-technologybusinessInfrared
researchProduct

Scene-based spectral calibration assessment of high spectral resolution imaging spectrometers

2009

An accurate knowledge of the spectral calibration of imaging spectrometers is required for optimum data processing and interpretation. The scene-based spectral characterization of imaging spectrometers is frequently necessary to update or replace the pre-flight laboratory-based spectral characterization supplied by the data provider. An automatic method for the estimation of spectral calibration parameters (channel position and bandwidth) at atmospheric absorption regions from high spectral resolution imaging spectrometers (spectral sampling interval below 5 nm) is presented in this contribution. The method has been tested on two commercial instruments with spectral sampling intervals below…

Optics and Photonicsmedicine.medical_specialtyTime FactorsNormal Distribution550 - Earth sciencesAutomationOpticsImage Processing Computer-AssistedmedicineSpectral resolutionRadiometric calibrationRemote sensingPhysicsSpectral signatureSpectrometerAtmospherebusiness.industryBandwidth (signal processing)Hyperspectral imagingAtomic and Molecular Physics and OpticsSpectral imagingSpectrometry FluorescenceSpectrophotometryFull spectral imagingCalibrationbusiness
researchProduct